Europe Western Blotting Market

Europe Western Blotting Market Size

The western blotting market in Europe was valued at USD 126.71 million in 2023. The European market is anticipated to grow at a CAGR of 5.3% from 2024 to 2032 and be worth USD 201.6 million by 2032 from USD 133.4 million in 2024.

MARKET DRIVERS

Factors such as Y-O-Y growth in the incidence of HIV, growing expenditure by the companies on R&D, the existence of favorable reimbursement policies, and government amendments are majorly boosting the growth of the western blotting market in the European region. Growth strategies adopted by key companies, such as mergers, acquisitions, the launch of new product developments, partnerships, and distribution agreements, are further expected to fuel market growth. Growing awareness regarding western blotting is another significant contributor to market growth in the European region.

MARKET RESTRAINTS

The availability of alternative technological methods is expected to hamper the market growth to a small extent. The lack of skilled and expert lab technicians in Europe is further impeding the regional market expansion.

REGIONAL ANALYSIS

Europe had the second-largest share of the global market in 2023. It can be attributed to factors such as growth in the proteomics market, the increasing number of industry-academic research collaborations, and the increase in personalized medicine requirements.

In this region, Germany is expected to lead the European Western Blotting Market during the forecast period due to the appearance of well-developed and mature organizations in the country and the rise of innovative technologies that drive the growth of the market.

The UK is next in line, accounting for the majority of market share in the market during the forecast period. The growing prevalence of Lyme and HIV diseases and increasing demand for proteomics and growing investments in the proteomics segment favor the UK market.

KEY MARKET PARTICIPANTS

Companies playing a notable role in the Europe western blotting market profiled in this report include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., GE Healthcare, Advansta, Inc., LI-COR Biosciences, PerkinElmer Inc., Bio-Techne Corporation, Merck KGaA, F. Hoffmann-La Roche Ltd., and Cell Signaling Technology.

MARKET SEGMENTATION

This research report on the Europe western blotting market is segmented and sub-segmented into the following categories.

By Product

• Instruments
• Consumables

By Application

• Biomedical & Biochemical Research
• Disease Diagnostics

By End User

• Academic & Research Institutes
• Pharmaceutical and Biotechnology Companies

By Country

• UK
• France
• Spain
• Germany
• Italy
• Russia
• Sweden
• Denmark
• Switzerland
• Netherlands
• Turkey
• Czech Republic
• Rest of Europe